TD Asset Management Inc Acquires 22,042 Shares of Cardinal Health, Inc. $CAH

TD Asset Management Inc raised its holdings in Cardinal Health, Inc. (NYSE:CAH) by 6.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 374,531 shares of the company’s stock after acquiring an additional 22,042 shares during the period. TD Asset Management Inc owned about 0.16% of Cardinal Health worth $76,966,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Versor Investments LP bought a new position in shares of Cardinal Health during the 3rd quarter worth $2,090,000. Nordea Investment Management AB grew its position in shares of Cardinal Health by 328.3% during the 4th quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock worth $133,741,000 after buying an additional 494,731 shares in the last quarter. Candriam S.C.A. grew its position in shares of Cardinal Health by 10.8% during the 3rd quarter. Candriam S.C.A. now owns 196,163 shares of the company’s stock worth $30,790,000 after buying an additional 19,155 shares in the last quarter. Victory Capital Management Inc. grew its position in shares of Cardinal Health by 44.9% during the 3rd quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock worth $352,165,000 after buying an additional 707,495 shares in the last quarter. Finally, Public Sector Pension Investment Board grew its position in shares of Cardinal Health by 66.7% during the 3rd quarter. Public Sector Pension Investment Board now owns 30,007 shares of the company’s stock worth $4,710,000 after buying an additional 12,003 shares in the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of CAH stock opened at $205.79 on Friday. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60. The stock’s 50-day moving average is $202.53 and its 200 day moving average is $208.57. The company has a market cap of $48.20 billion, a P/E ratio of 31.47, a PEG ratio of 1.10 and a beta of 0.52.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. During the same quarter last year, the company earned $2.35 earnings per share. The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a yield of 1.0%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s dividend payout ratio (DPR) is 31.19%.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on CAH shares. Morgan Stanley increased their price target on Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 28th. JPMorgan Chase & Co. dropped their price objective on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research report on Monday, May 4th. Weiss Ratings downgraded Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research report on Tuesday, May 19th. Wells Fargo & Company dropped their price objective on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Finally, Barclays raised their price objective on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, February 24th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and an average price target of $241.80.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.